<?xml version="1.0" encoding="utf-8"?>
<rdf:Description rdf:about="http://archives.rcpe.ac.uk/CalmView/record/catalog/RCP/COL/9/923" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Consultation response to the National Institute for Health and Clinical Excellence on '(1) Proposed Health Technology Appraisal - Lapatinib for breast cancer (First line use in advanced or metastatic hormone-sensitive breast cancer) - draft remit and draft scope' and '(2) Proposed Health Technology Appraisal - Lapatinib for breast cancer (For use in women with previously treated, advanced or metastatic breast cancer) - draft remit and draft scope'</dc:title>
  <dc:description></dc:description>
  <dc:date>2006</dc:date>
</rdf:Description>